BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29924296)

  • 1. ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patients.
    Hutchings M; Ladetto M; Buske C; de Nully Brown P; Ferreri AJM; Pfreundschuh M; Schmitz N; Balari AS; van Imhoff G; Walewski J;
    Ann Oncol; 2018 Aug; 29(8):1687-1700. PubMed ID: 29924296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia.
    Ladetto M; Buske C; Hutchings M; Dreyling M; Gaidano G; Le Gouill S; Luminari S; Pott C; Zamò A; Zucca E;
    Ann Oncol; 2016 Dec; 27(12):2149-2160. PubMed ID: 27701070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma.
    Buske C; Hutchings M; Ladetto M; Goede V; Mey U; Soubeyran P; Spina M; Stauder R; Trněný M; Wedding U; Fields P;
    Ann Oncol; 2018 Mar; 29(3):544-562. PubMed ID: 29194473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up.
    Honecker F; Aparicio J; Berney D; Beyer J; Bokemeyer C; Cathomas R; Clarke N; Cohn-Cedermark G; Daugaard G; Dieckmann KP; Fizazi K; Fosså S; Germa-Lluch JR; Giannatempo P; Gietema JA; Gillessen S; Haugnes HS; Heidenreich A; Hemminki K; Huddart R; Jewett MAS; Joly F; Lauritsen J; Lorch A; Necchi A; Nicolai N; Oing C; Oldenburg J; Ondruš D; Papachristofilou A; Powles T; Sohaib A; Ståhl O; Tandstad T; Toner G; Horwich A
    Ann Oncol; 2018 Aug; 29(8):1658-1686. PubMed ID: 30113631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.
    Colombo N; Creutzberg C; Amant F; Bosse T; González-Martín A; Ledermann J; Marth C; Nout R; Querleu D; Mirza MR; Sessa C;
    Int J Gynecol Cancer; 2016 Jan; 26(1):2-30. PubMed ID: 26645990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up.
    Colombo N; Creutzberg C; Amant F; Bosse T; González-Martín A; Ledermann J; Marth C; Nout R; Querleu D; Mirza MR; Sessa C;
    Radiother Oncol; 2015 Dec; 117(3):559-81. PubMed ID: 26683800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†.
    Colombo N; Sessa C; du Bois A; Ledermann J; McCluggage WG; McNeish I; Morice P; Pignata S; Ray-Coquard I; Vergote I; Baert T; Belaroussi I; Dashora A; Olbrecht S; Planchamp F; Querleu D;
    Ann Oncol; 2019 May; 30(5):672-705. PubMed ID: 31046081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee.
    Keilholz U; Ascierto PA; Dummer R; Robert C; Lorigan P; van Akkooi A; Arance A; Blank CU; Chiarion Sileni V; Donia M; Faries MB; Gaudy-Marqueste C; Gogas H; Grob JJ; Guckenberger M; Haanen J; Hayes AJ; Hoeller C; Lebbé C; Lugowska I; Mandalà M; Márquez-Rodas I; Nathan P; Neyns B; Olofsson Bagge R; Puig S; Rutkowski P; Schilling B; Sondak VK; Tawbi H; Testori A; Michielin O
    Ann Oncol; 2020 Nov; 31(11):1435-1448. PubMed ID: 32763453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee.
    Michielin O; van Akkooi A; Lorigan P; Ascierto PA; Dummer R; Robert C; Arance A; Blank CU; Chiarion Sileni V; Donia M; Faries MB; Gaudy-Marqueste C; Gogas H; Grob JJ; Guckenberger M; Haanen J; Hayes AJ; Hoeller C; Lebbé C; Lugowska I; Mandalà M; Márquez-Rodas I; Nathan P; Neyns B; Olofsson Bagge R; Puig S; Rutkowski P; Schilling B; Sondak VK; Tawbi H; Testori A; Keilholz U
    Ann Oncol; 2020 Nov; 31(11):1449-1461. PubMed ID: 32763452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.
    Colombo N; Creutzberg C; Amant F; Bosse T; González-Martín A; Ledermann J; Marth C; Nout R; Querleu D; Mirza MR; Sessa C;
    Ann Oncol; 2016 Jan; 27(1):16-41. PubMed ID: 26634381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Eichenauer DA; Aleman BMP; André M; Federico M; Hutchings M; Illidge T; Engert A; Ladetto M;
    Ann Oncol; 2018 Oct; 29(Suppl 4):iv19-iv29. PubMed ID: 29796651
    [No Abstract]   [Full Text] [Related]  

  • 12. Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference.
    Berenguer M; Burra P; Ghobrial M; Hibi T; Metselaar H; Sapisochin G; Bhoori S; Kwan Man N; Mas V; Ohira M; Sangro B; van der Laan LJW
    Transplantation; 2020 Jun; 104(6):1143-1149. PubMed ID: 32217940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease.
    Colombo N; Sessa C; Bois AD; Ledermann J; McCluggage WG; McNeish I; Morice P; Pignata S; Ray-Coquard I; Vergote I; Baert T; Belaroussi I; Dashora A; Olbrecht S; Planchamp F; Querleu D;
    Int J Gynecol Cancer; 2019 May; ():. PubMed ID: 31048403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.
    Horwich A; Babjuk M; Bellmunt J; Bruins HM; De Reijke TM; De Santis M; Gillessen S; James N; Maclennan S; Palou J; Powles T; Ribal MJ; Shariat SF; Van Der Kwast T; Xylinas E; Agarwal N; Arends T; Bamias A; Birtle A; Black PC; Bochner BH; Bolla M; Boormans JL; Bossi A; Briganti A; Brummelhuis I; Burger M; Castellano D; Cathomas R; Chiti A; Choudhury A; Compérat E; Crabb S; Culine S; De Bari B; DeBlok W; De Visschere PJL; Decaestecker K; Dimitropoulos K; Dominguez-Escrig JL; Fanti S; Fonteyne V; Frydenberg M; Futterer JJ; Gakis G; Geavlete B; Gontero P; Grubmüller B; Hafeez S; Hansel DE; Hartmann A; Hayne D; Henry AM; Hernandez V; Herr H; Herrmann K; Hoskin P; Huguet J; Jereczek-Fossa BA; Jones R; Kamat AM; Khoo V; Kiltie AE; Krege S; Ladoire S; Lara PC; Leliveld A; Linares-Espinós E; Løgager V; Lorch A; Loriot Y; Meijer R; Carmen Mir M; Moschini M; Mostafid H; Müller AC; Müller CR; N'Dow J; Necchi A; Neuzillet Y; Oddens JR; Oldenburg J; Osanto S; Oyen WJG; Pacheco-Figueiredo L; Pappot H; Patel MI; Pieters BR; Plass K; Remzi M; Retz M; Richenberg J; Rink M; Roghmann F; Rosenberg JE; Rouprêt M; Rouvière O; Salembier C; Salminen A; Sargos P; Sengupta S; Sherif A; Smeenk RJ; Smits A; Stenzl A; Thalmann GN; Tombal B; Turkbey B; Vahr Lauridsen S; Valdagni R; Van Der Heijden AG; Van Poppel H; Vartolomei MD; Veskimäe E; Vilaseca A; Vives Rivera FA; Wiegel T; Wiklund P; Williams A; Zigeuner R; Witjes JA
    Ann Oncol; 2019 Nov; 30(11):1697-1727. PubMed ID: 31740927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL).
    Ghielmini M; Vitolo U; Kimby E; Montoto S; Walewski J; Pfreundschuh M; Federico M; Hoskin P; McNamara C; Caligaris-Cappio F; Stilgenbauer S; Marcus R; Trneny M; Dreger P; Montserrat E; Dreyling M;
    Ann Oncol; 2013 Mar; 24(3):561-76. PubMed ID: 23175624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3).
    Paluch-Shimon S; Pagani O; Partridge AH; Abulkhair O; Cardoso MJ; Dent RA; Gelmon K; Gentilini O; Harbeck N; Margulies A; Meirow D; Pruneri G; Senkus E; Spanic T; Sutliff M; Travado L; Peccatori F; Cardoso F
    Breast; 2017 Oct; 35():203-217. PubMed ID: 28822332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Kastritis E; Leblond V; Dimopoulos MA; Kimby E; Staber P; Kersten MJ; Tedeschi A; Buske C;
    Ann Oncol; 2018 Oct; 29(Suppl 4):iv41-iv50. PubMed ID: 29982402
    [No Abstract]   [Full Text] [Related]  

  • 18. ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.
    Ledermann JA; Matias-Guiu X; Amant F; Concin N; Davidson B; Fotopoulou C; González-Martin A; Gourley C; Leary A; Lorusso D; Banerjee S; Chiva L; Cibula D; Colombo N; Croce S; Eriksson AG; Falandry C; Fischerova D; Harter P; Joly F; Lazaro C; Lok C; Mahner S; Marmé F; Marth C; McCluggage WG; McNeish IA; Morice P; Nicum S; Oaknin A; Pérez-Fidalgo JA; Pignata S; Ramirez PT; Ray-Coquard I; Romero I; Scambia G; Sehouli J; Shapira-Frommer R; Sundar S; Tan DSP; Taskiran C; van Driel WJ; Vergote I; Planchamp F; Sessa C; Fagotti A
    Ann Oncol; 2024 Mar; 35(3):248-266. PubMed ID: 38307807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.
    Passaro A; Leighl N; Blackhall F; Popat S; Kerr K; Ahn MJ; Arcila ME; Arrieta O; Planchard D; de Marinis F; Dingemans AM; Dziadziuszko R; Faivre-Finn C; Feldman J; Felip E; Curigliano G; Herbst R; Jänne PA; John T; Mitsudomi T; Mok T; Normanno N; Paz-Ares L; Ramalingam S; Sequist L; Vansteenkiste J; Wistuba II; Wolf J; Wu YL; Yang SR; Yang JCH; Yatabe Y; Pentheroudakis G; Peters S
    Ann Oncol; 2022 May; 33(5):466-487. PubMed ID: 35176458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Casali PG; Abecassis N; Aro HT; Bauer S; Biagini R; Bielack S; Bonvalot S; Boukovinas I; Bovee JVMG; Brodowicz T; Broto JM; Buonadonna A; De Álava E; Dei Tos AP; Del Muro XG; Dileo P; Eriksson M; Fedenko A; Ferraresi V; Ferrari A; Ferrari S; Frezza AM; Gasperoni S; Gelderblom H; Gil T; Grignani G; Gronchi A; Haas RL; Hassan B; Hohenberger P; Issels R; Joensuu H; Jones RL; Judson I; Jutte P; Kaal S; Kasper B; Kopeckova K; Krákorová DA; Le Cesne A; Lugowska I; Merimsky O; Montemurro M; Pantaleo MA; Piana R; Picci P; Piperno-Neumann S; Pousa AL; Reichardt P; Robinson MH; Rutkowski P; Safwat AA; Schöffski P; Sleijfer S; Stacchiotti S; Sundby Hall K; Unk M; Van Coevorden F; van der Graaf WTA; Whelan J; Wardelmann E; Zaikova O; Blay JY;
    Ann Oncol; 2018 Oct; 29(Suppl 4):iv51-iv67. PubMed ID: 29846498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.